Carole Nuechterlein, Director, 10% Owner at Aligos Therapeutics, Inc. (ALGS), bought 15,867,202 shares at $0.76 ($12.1M) on 2023-10-25, disclosed to the SEC on 2023-10-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.76 | 7,933,601 | $6.0M | 50.0% |
| 2 | $0.76 | 7,933,601 | $6.0M | 50.0% |
| Total | $0.76 avg | 15,867,202 | $12.1M | 100% |